Adherence to the EAT–Lancet diet and neuropsychiatric disorders: a systematic review and meta-analysis
Psychological Medicine · 2026 · 56
DOI: 10.1017/s0033291726104528 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Psychological Medicine, online erschienen am 01.06.2026. Verfasst von Yuhao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, the Second Xiangya Hospit…. Hauptthemen laut MEDLINE: Mental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neuropsychiatric disorders (NPDs) are a leading cause of disability worldwide. The predominantly plant-based EAT–Lancet diet has been proposed to confer neuropsychiatric benefits, yet evidence remains limited. This study synthesized associations between adherence to the EAT–Lancet diet and neuropsychiatric outcomes. We searched PubMed, Web of Science, Embase, Scopus, and ProQuest Dissertations and Theses Global through September 4, 2025. Observational studies reporting associations between EAT–Lancet adherence and NPDs were included. Binary outcomes were pooled as hazard ratios (HRs) or odds ratios (ORs), and continuous outcomes as regression coefficients (β). Subgroup, sensitivity, and publication-bias analyses were performed. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework (GRADE). Twenty-two cohort and six cross-sectional studies were included. Higher adherence to the EAT–Lancet diet was associated with lower risks of depression (OR 0.76; 95% CI 0.71–0.81), anxiety (OR 0.82; 0.76–0.89), stroke (HR 0.84; 0.76–0.92), and dementia (HR 0.96; 0.93–1.00), whereas no significant association was observed for global cognitive function (β 0.02; −0.01 to 0.06). Sensitivity analyses supported robustness. Certainty of evidence was very low for anxiety, depression, and cognition, and low for stroke and dementia. Greater adherence to the EAT–Lancet diet was associated with lower risks of depression, anxiety, stroke, and dementia. However, given the low certainty of evidence, findings should be interpreted cautiously. Further large prospective studies and randomized controlled trials are warranted to improve evidence quality and clarify the potential role of the EAT–Lancet diet in neuropsychiatric disease prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, the Second Xiangya Hospital of Central South University, Changsha410011, Hunan, China.
- Xiangya School of Medicine, Central South University, Changsha410011, Hunan, China, China.
- School of Medicine, Zhejiang University, Hangzhou310000, China.
- School of Biological Science and Medical Engineering, Beihang University, 100191, Beijing, China.
ORCID-Profile: Yumeng Ju
Zitieren
APA
Wang, Y., Li, Z., Wu, Z., Hu, W., Wu, H., Hu, Y., Ju, Y., & Zhang, Y. (2026). Adherence to the EAT–Lancet diet and neuropsychiatric disorders: a systematic review and meta-analysis. Psychological Medicine, 56. https://doi.org/10.1017/s0033291726104528
Vancouver
Wang Y, Li Z, Wu Z, Hu W, Wu H, Hu Y, et al. Adherence to the EAT–Lancet diet and neuropsychiatric disorders: a systematic review and meta-analysis. Psychological Medicine. 2026;56. doi:10.1017/s0033291726104528
BibTeX
@article{Wang2026,
author = {Wang, Yuhao and Li, Zejun and Wu, Zongze and Hu, Wei and Wu, Hao and Hu, Yuchang and Ju, Yumeng and Zhang, Yan},
title = {Adherence to the EAT–Lancet diet and neuropsychiatric disorders: a systematic review and meta-analysis},
journal = {Psychological Medicine},
year = {2026},
volume = {56},
doi = {10.1017/s0033291726104528}
}
EUVIMED